Mackay Shields LLC’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,740
| Closed | -$1.46M | – | 881 |
|
|
2021
Q1 | $1.46M | Sell |
15,740
-10,737
| -41% | -$998K | 0.01% | 885 |
|
|
2020
Q4 | $2.37M | Sell |
26,477
-3,886
| -13% | -$348K | 0.02% | 791 |
|
|
2020
Q3 | $3.14M | Buy |
30,363
+2,386
| +9% | +$247K | 0.02% | 594 |
|
|
2020
Q2 | $2.21M | Sell |
27,977
-1,600
| -5% | -$127K | 0.02% | 705 |
|
|
2020
Q1 | $1.71M | Sell |
29,577
-1,600
| -5% | -$92.6K | 0.02% | 732 |
|
|
2019
Q4 | $1.68M | Sell |
31,177
-8,300
| -21% | -$448K | 0.01% | 934 |
|
|
2019
Q3 | $2.06M | Sell |
39,477
-3,000
| -7% | -$157K | 0.01% | 887 |
|
|
2019
Q2 | $2.05M | Buy |
42,477
+25,937
| +157% | +$1.25M | 0.01% | 888 |
|
|
2019
Q1 | $836K | Sell |
16,540
-1,800
| -10% | -$91K | 0.01% | 1054 |
|
|
2018
Q4 | $1.09M | Sell |
18,340
-4,440
| -19% | -$263K | 0.01% | 907 |
|
|
2018
Q3 | $1.5M | Buy |
22,780
+7,200
| +46% | +$474K | 0.01% | 781 |
|
|
2018
Q2 | $787K | Sell |
15,580
-2,000
| -11% | -$101K | 0.01% | 1016 |
|
|
2018
Q1 | $926K | Buy |
+17,580
| New | +$926K | 0.01% | 994 |
|